Skip to content
Single Family OfficeAllocates capital directlyLAST VERIFIED Oct 2026 · 2 SOURCES

Wieland Capital

Munich family office founded 2004 by Robert Wieland; invests own family wealth in DACH Mittelstand companies (EUR 2–7M equity), growth/VC deals and residential property.

USEFUL FOR Business owners seeking a long-term partner · Co-investors

Family & background

FAMILY
Wieland
WEALTH ORIGIN
Sale of ESPE, a dental company founded by Robert Wieland's grandfather
HEADQUARTERS
Munich, Germany
FOUNDED
2004
OUTSIDE CAPITAL
No — own capital only

Investment approach

SECTORS
HealthTechBiotech & Life SciencesIndustrial & ManufacturingSoftware & SaaSConsumer & E-commerceReal Estate & PropTech
GEOGRAPHY
GermanyAustriaSwitzerland
STAGES
GrowthBuyout
ROUTES
Direct investments
STRATEGIES
Private equityVenture capitalReal estateDirect investments
TICKET
€2M–€7M

Overview

Wieland Capital is a Munich family office that invests its own family wealth; Robert Wieland founded it in 2004 after the sale of ESPE, a dental company founded by his grandfather. It takes stakes in profitable mid-sized companies, mainly in the DACH region and across sectors, typically alongside founders and management in succession deals, and in selected growth and venture situations. It also holds existing residential property in Berlin, Leipzig and Dresden, forestry and other liquid and illiquid assets.

Investment thesis

Profitable, established DACH Mittelstand companies with a strong management team, often in succession situations; sector-agnostic, EUR 2–7M equity per deal with co-investors for larger deals, long-term holding with no pressure to sell.

Holdings & investments (15)

  • Inductio
    HealthTech · since 2024
  • Cycuria
    Biotech & Life Sciences · since 2024
  • dawn-bio
    Biotech & Life Sciences · since 2024
  • RoamsysNext
    Software & SaaS · since 2023
  • Plasmion
    Deep Tech · since 2022
  • i3 Membrane
    Industrial & Manufacturing · since 2021
  • PhagoMed
    Biotech & Life Sciences · since 2020 · Acquired (sold to BioNTech, 2021)
  • noscendo
    HealthTech · since 2018
  • Lifespin
    HealthTech · since 2017
  • Schlafender Hase
    Software & SaaS · since 2017
  • HKT-Kabeltechnik
    Industrial & Manufacturing · since 2016
  • Ceranovis
    Industrial & Manufacturing · since 2016
  • Care
    HealthTech · since 2015
  • REMEMBER
    Consumer & E-commerce · since 2009 · Exited (sold to Verdane, 2021)
  • Peptido
    Biotech & Life Sciences · since 2007

People

  • Robert Wieland
    Founder and Partner; Managing Director · source
  • Franck Godet
    Partner; Managing Director · source
  • Melissa Simon
    Partner · source

Classification

Single Family Office. Manages one family's own capital, with no outside investors. The family bears every loss. How family capital is classified →

FAQ

Wieland Capital is a single family office based in Munich, Germany, founded in 2004.

Wieland Capital invests on behalf of the Wieland family (Sale of ESPE, a dental company founded by Robert Wieland's grandfather).

Wieland Capital invests directly in companies. Its stated asset mix includes private equity, venture capital, real estate and direct investments.

Wieland Capital invests at Growth and Buyout stages in HealthTech, Biotech & Life Sciences, Industrial & Manufacturing, Software & SaaS, Consumer & E-commerce and Real Estate & PropTech.

Wieland Capital's stated ticket size is €2M–€7M.

Key people at Wieland Capital include Robert Wieland (Founder and Partner; Managing Director), Franck Godet (Partner; Managing Director) and Melissa Simon (Partner).

Wieland Capital's holdings and investments include Peptido, REMEMBER, Care, HKT-Kabeltechnik, Ceranovis, Lifespin, Schlafender Hase and noscendo, among others.

No. Wieland Capital invests its own capital and does not raise money from outside investors.